Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jongwon Lim

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4Jongwon Lim, Michael D Altman, James Baker, et al.
Molecular Cancer Research : MCR|April 23, 2014
Evaluating TBK1 as a therapeutic target in cancers with activated IRF3Asli Muvaffak, Qi Pan, Haiyan Yan, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Plos One|May 25, 2012
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia veraManfred Kraus, Yuxun Wang, Dan Aleksandrowicz, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2017
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammationGraham F Smith, Michael D Altman, Brian Andresen, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Journal of Medicinal Chemistry|March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of CancerRyan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4Jongwon Lim, Michael D Altman, James Baker, et al.
Molecular Cancer Research : MCR|April 23, 2014
Evaluating TBK1 as a therapeutic target in cancers with activated IRF3Asli Muvaffak, Qi Pan, Haiyan Yan, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Journal of Medicinal Chemistry|February 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven MalignanciesBrandon A Vara, Jongwon Lim, Casey J Moure, et al.
Plos One|May 25, 2012
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia veraManfred Kraus, Yuxun Wang, Dan Aleksandrowicz, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2017
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammationGraham F Smith, Michael D Altman, Brian Andresen, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Journal of Medicinal Chemistry|March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of CancerRyan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Pageof 6